Brian Piekos - 18 Oct 2021 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
Chief Financial Officer
Signature
/s/ Jason Meyenburg, attorney-in-fact
Issuer symbol
IRON
Transactions as of
18 Oct 2021
Transactions value $
$0
Form type
4
Date filed
20 Oct 2021, 17:49
Previous filing
18 May 2021
Next filing
14 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Restricted Stock Units Award $0 +90.7K $0.00 90.7K 18 Oct 2021 Common Stock 90.7K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
F2 Thirty-three percent (33%) of the Restricted Stock Units shall vest upon the achievement of a clinical milestone, and the remaining sixty-seven percent (67%) of the Restricted Stock Units shall vest on the one (1)-year anniversary of the achievement of this clinical milestone.